Giulia Ciotti

Istituto Oncologico Veneto

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

MARIA TERESA BOCHICCHIO

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

ITALY

View details

GIORGIA SIMONETTI

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori

ITALY

View details

Agostino Chiaravalloti

UNIVERSITY TOR VERGATA

ITALY

View details

Francesco Buccisano

Associate Professor

UNIVERSITY TOR VERGATA

ITALY

View details

Ilaria DEL GIUDICE

Sapienza University of Rome

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giulia Ciotti

Research Interests

Explore related searches

Contact this professor

Articles (11)

New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers

Impact of Pre‐Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents

Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing

The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study

Biological therapy in elderly patients with acute myeloid leukemia

2-Hydroxyglutarate in Acute Myeloid Leukemia: A Journey from Pathogenesis to Therapies

Utility of procalcitonin and C-reactive protein as predictors of Gram-negative bacteremia in febrile hematological outpatients

Hypomethylating Agent-Based Combination Therapies to Treat Post-Hematopoietic Stem Cell Transplant Relapse of Acute Myeloid Leukemia

Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic

High Basal Maximal Standardized Uptake Value (SUVmax) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse

Measuring prognosis in chronic myeloid leukemia: what’s new?

Collaborators (5)

MARIA TERESA BOCHICCHIO

GIORGIA SIMONETTI

Agostino Chiaravalloti

Francesco Buccisano

Ilaria DEL GIUDICE

Make your next move.